A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors
Clinical trial NCT07744763 · RECRUITING
Trial details
- NCT number
- NCT07744763
- Sponsor
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2027-03-28
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.